CONSOLIDATED STATEMENTS OF SHAREHOLDERS (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Jan. 29, 2022	$ 81,126	$ 175,856	$ (94,730)
Balance, beginning of period (in shares) at Jan. 29, 2022		12,631,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	16	$ 16
Exercise of stock options (in shares)		2,705
Restricted stock issued		826,423
Net share settlement of stock options and restricted stock units	(2,383)	$ (2,383)
Net share settlement of stock options and restricted stock units (in shares)		(226,141)
Stock-based compensation expense	1,961	$ 1,961
Repurchase and retirement of common stock	$ (6,253)		(6,253)
Repurchase and retirement of common stock (in shares)	(479,966)	(479,966)
Net Income (Loss)	$ (44,694)		(44,694)
Balance, end of period at Jan. 28, 2023	29,773	$ 175,450	(145,677)
Balance, end of period (in shares) at Jan. 28, 2023		12,754,368
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	0
Restricted stock issued		202,967
Net share settlement of restricted stock units	(84)	$ (84)
Net share settlement of restricted stock units (in shares)		(31,313)
Stock-based compensation expense	$ 1,186	$ 1,186
Repurchase and retirement of common stock (in shares)	0
Net Income (Loss)	$ (27,751)		(27,751)
Balance, end of period at Feb. 03, 2024	$ 3,124	$ 176,552	(173,428)
Balance, end of period (in shares) at Feb. 03, 2024	12,926,022	12,926,022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 0
Restricted stock issued		215,591
Net share settlement of restricted stock units	(51)	$ (51)
Net share settlement of restricted stock units (in shares)		(23,671)
Stock-based compensation expense	$ 1,042	$ 1,042
Repurchase and retirement of common stock (in shares)	0
Net Income (Loss)	$ (23,132)		(23,132)
Balance, end of period at Feb. 01, 2025	$ (19,017)	$ 177,543	$ (196,560)
Balance, end of period (in shares) at Feb. 01, 2025	13,117,942	13,117,942